Middleton K et al. |
Microfluidic co-culture platform for investigating osteocyte-osteoclast signalling during fluid shear stress mechanostimulation. |
2017 |
J Biomech |
pmid:28552413
|
Jung YJ et al. |
Tannerella forsythia GroEL induces inflammatory bone resorption and synergizes with interleukin-17. |
2017 |
Mol Oral Microbiol |
pmid:27484636
|
Lu LY et al. |
Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway. |
2017 |
J. Orthop. Res. |
pmid:28248001
|
Kuroyanagi G et al. |
(-)-Epigallocatechin gallate synergistically potentiates prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. |
2017 |
Prostaglandins Other Lipid Mediat. |
pmid:28163121
|
Liu XY et al. |
Protective effects of total flavonoids of Astragalus against adjuvant-induced arthritis in rats by regulating OPG/RANKL/NF-κB pathway. |
2017 |
Int. Immunopharmacol. |
pmid:28092862
|
Choi EM et al. |
Actein alleviates 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated cellular dysfunction in osteoblastic MC3T3-E1 cells. |
2017 |
Environ. Toxicol. |
pmid:28836330
|
Chen X et al. |
Emodin suppresses cadmium-induced osteoporosis by inhibiting osteoclast formation. |
2017 |
Environ. Toxicol. Pharmacol. |
pmid:28738286
|
Ozaki Y et al. |
Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis. |
2017 |
PLoS ONE |
pmid:28937990
|
Tschiderer L et al. |
Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants. |
2017 |
PLoS ONE |
pmid:28837646
|
Åšliwicka E et al. |
Serum irisin and myostatin levels after 2 weeks of high-altitude climbing. |
2017 |
PLoS ONE |
pmid:28732027
|
Bergdolt S et al. |
Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing. |
2017 |
PLoS ONE |
pmid:28614388
|
Spirlandeli AL et al. |
Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment. |
2017 |
Clinics (Sao Paulo) |
pmid:28492723
|
Liu J et al. |
MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification. |
2017 |
PLoS ONE |
pmid:28319142
|
Songia P et al. |
Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model. |
2017 |
Oxid Med Cell Longev |
pmid:28261377
|
Jia J et al. |
Estrogen stimulates osteoprotegerin expression via the suppression of miR-145 expression in MG-63 cells. |
2017 |
Mol Med Rep |
pmid:28260003
|
Shetelig C et al. |
Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function. |
2017 |
PLoS ONE |
pmid:28253327
|
Irtyuga O et al. |
NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL. |
2017 |
Biomed Res Int |
pmid:28246602
|
Hanmoto T et al. |
Effects of low-intensity pulsed ultrasound on osteoclasts: Analysis with goldfish scales as a model of bone. |
2017 |
Biomed. Res. |
pmid:28239034
|
Fioramonti M et al. |
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions. |
2017 |
Oncotarget |
pmid:28223547
|
Xiong L et al. |
Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling. |
2017 |
J. Cell Biol. |
pmid:28193701
|
Fortner RT et al. |
Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort. |
2017 |
BMC Med |
pmid:28173834
|
Chung ST et al. |
Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells. |
2017 |
Mol. Cancer |
pmid:28143606
|
Yin LL et al. |
Relationship between the gene polymorphism of osteoprotegerin and bone mineral density in hemodialysis patients. |
2017 |
Eur Rev Med Pharmacol Sci |
pmid:28121359
|
Bondar C et al. |
Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease. |
2017 |
Int J Mol Sci |
pmid:28098793
|
Shu R et al. |
Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement. |
2017 |
PLoS ONE |
pmid:28081119
|
Ji J et al. |
Pathway of 3-MCPD-induced apoptosis in human embryonic kidney cells. |
2017 |
J Toxicol Sci |
pmid:28070108
|
Sponder M et al. |
Endurance training significantly increases serum endocan but not osteoprotegerin levels: a prospective observational study. |
2017 |
BMC Cardiovasc Disord |
pmid:28056805
|
Hygum K et al. |
MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. |
2017 |
Eur. J. Endocrinol. |
pmid:28049653
|
Dawson S and Lawrie A |
From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease. |
2017 |
Pharmacol. Ther. |
pmid:27373854
|
Yu M et al. |
Chemotherapy effectively suppresses interleukin-20, receptor activator of nuclear factor kappa-B ligand, and osteoprotegerin levels in patients with lung adenocarcinoma and bone metastasis. |
2016 Apr-Jun |
J Cancer Res Ther |
pmid:27461682
|
Moran CS et al. |
Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II-Infused Apolipoprotein E-Deficient Mouse. |
2016 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:26966276
|
Zhou QL et al. |
Polydatin possesses notable anti‑osteoporotic activity via regulation of OPG, RANKL and β‑catenin. |
2016 |
Mol Med Rep |
pmid:27357904
|
Cong Q et al. |
p38α MAPK Regulates Lineage Commitment and OPG Synthesis of Bone Marrow Stromal Cells to Prevent Bone Loss under Physiological and Pathological Conditions. |
2016 |
Stem Cell Reports |
pmid:26947973
|
Wang C et al. |
Adenovirus-mediated siRNA targeting CXCR2 attenuates titanium particle-induced osteolysis by suppressing osteoclast formation. |
2016 |
Med. Sci. Monit. |
pmid:26939934
|
Lin J et al. |
Increased generation of Foxp3(+) regulatory T cells by manipulating antigen presentation in the thymus. |
2016 |
Nat Commun |
pmid:26923114
|
D'Abramo A et al. |
Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients. |
2016 |
PLoS ONE |
pmid:26913505
|
Lu J et al. |
Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats. |
2016 |
Exp. Biol. Med. (Maywood) |
pmid:26908571
|
Theodoro LH et al. |
Effect of low-level laser therapy as an adjuvant in the treatment of periodontitis induced in rats subjected to 5-fluorouracil chemotherapy. |
2016 |
J. Periodont. Res. |
pmid:26750739
|
Alam I et al. |
Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice. |
2016 |
Endocrinology |
pmid:26584014
|
Mitchell JA et al. |
Genetic Risk Scores Implicated in Adult Bone Fragility Associate With Pediatric Bone Density. |
2016 |
J. Bone Miner. Res. |
pmid:26572781
|
Liu G et al. |
Endoplasmic reticulum stress-mediated inflammatory signaling pathways within the osteolytic periosteum and interface membrane in particle-induced osteolysis. |
2016 |
Cell Tissue Res. |
pmid:26004143
|
Bergamini A et al. |
Expression of the receptor activator of nuclear factor-kB ligand in peripheral blood mononuclear cells in patients with acute Charcot neuroarthropathy. |
2016 |
Int J Med Sci |
pmid:28090190
|
Toffoli B et al. |
Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System. |
2016 |
Mediators Inflamm. |
pmid:28070143
|
Chen H et al. |
[Effects of laser solid forming of porous titanium on proliferation of osteoblast and RANKL/OPG expression]. |
2016 |
Zhong Nan Da Xue Xue Bao Yi Xue Ban |
pmid:28070039
|
Piemontese M et al. |
Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. |
2016 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:27460899
|
Zhao JJ et al. |
MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway. |
2016 |
PLoS ONE |
pmid:27459539
|
Ugay L et al. |
Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary Disease. |
2016 |
Chin. Med. J. |
pmid:27411457
|
Pellegrini GG et al. |
Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner. |
2016 |
Nutrients |
pmid:27409635
|
Nagy EE et al. |
High circulating osteoprotegerin levels are associated with non-zero blood groups. |
2016 |
BMC Cardiovasc Disord |
pmid:27387019
|
Zhang YY et al. |
Osteoprotegerin Promotes Cementoblastic Activity of Murine Cementoblast Cell Line in vitro. |
2016 |
Chin J Dent Res |
pmid:27379348
|